Marker Therapeutics, Inc. (MRKR)

NASDAQ: MRKR · IEX Real-Time Price · USD

5.05

-0.46 (-8.44%)

At close: Jul 19, 2024, 4:00 PM

4.990

-0.050 (-1.09%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Marker Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Revenue	3.32	3.31	3.51	1.24	0.47	0.21	Upgrade
Revenue Growth (YoY)	-12.23%	-5.76%	182.96%	166.01%	118.95%	3.50%	Upgrade
Gross Profit	3.32	3.31	3.51	1.24	0.47	0.21	Upgrade
Selling, General & Admin	6.53	7.48	11.34	12.92	10.47	9.98	Upgrade
Research & Development	9.62	10.42	11.97	27.79	18.88	12.76	Upgrade
Operating Expenses	16.14	17.89	23.3	40.72	29.35	22.74	Upgrade
Operating Income	-12.82	-14.58	-19.79	-39.48	-28.89	-22.53	Upgrade
Other Expense / Income	-7.16	-6.35	10.14	2.4	-0.18	-1.1	Upgrade
Pretax Income	-5.66	-8.23	-29.93	-41.88	-28.71	-21.43	Upgrade
Income Tax	0	0	0	0	0	0	Upgrade
Net Income	-5.66	-8.24	-29.93	-41.88	-28.71	-21.43	Upgrade
Shares Outstanding (Basic)	9	9	8	8	5	5	Upgrade
Shares Outstanding (Diluted)	9	9	8	8	5	5	Upgrade
Shares Change	2.07%	5.49%	9.16%	62.64%	3.19%	138.78%	Upgrade
EPS (Basic)	-0.64	-0.94	-3.58	-5.47	-6.10	-4.70	Upgrade
EPS (Diluted)	-0.64	-0.94	-3.58	-5.47	-6.10	-4.70	Upgrade
Free Cash Flow	-14.28	-16.44	-26.97	-30.41	-29.29	-18.66	Upgrade
Free Cash Flow Per Share	-1.60	-1.87	-3.23	-3.98	-6.23	-4.09	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-386.07%	-440.37%	-563.28%	-3179.32%	-6188.25%	-10567.28%	Upgrade
Profit Margin	-170.50%	-248.76%	-851.87%	-3372.68%	-6149.74%	-10050.92%	Upgrade
Free Cash Flow Margin	-429.89%	-496.51%	-767.66%	-2449.11%	-6274.32%	-8752.25%	Upgrade
EBITDA	-6.63	-8.23	-29.93	-38.72	-27.63	-21.14	Upgrade
EBITDA Margin	-199.65%	-248.65%	-851.87%	-3117.98%	-5919.30%	-9916.50%	Upgrade
Depreciation & Amortization	-0.97	0	0	3.16	1.08	0.29	Upgrade
EBIT	-5.66	-8.23	-29.93	-41.88	-28.71	-21.43	Upgrade
EBIT Margin	-170.39%	-248.65%	-851.87%	-3372.68%	-6149.74%	-10050.92%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).